Color Doppler ultrasound differentiates Graves' disease from silent thyroiditis in thyrotoxicosis patients
This was a single-center prospective observational cohort study conducted at Fundación Valle del Lili in Cali, Colombia, between January 2022 and October 2024. The study included 78 adult patients diagnosed with thyrotoxicosis and aimed to differentiate Graves' disease from silent thyroiditis using color Doppler ultrasound (CDU) with measurement of thyroid artery systolic velocities, compared to thyroid scintigraphy with Tc99 and anti-thyroid-stimulating hormone receptor antibodies (TRABs).
The main results showed that 28 out of 29 patients with thyroiditis (96.6%) had superior thyroid artery systolic velocities (STV) <43 cm/s, and 25 out of 29 cases (86.2%) had thyroid tissue blood flow (TBF) <14.1%. For scintigraphy, a diffusely increased pattern plus a trapping percentage higher than 4.9% had a sensitivity of 80% and specificity of 90% for Graves' disease diagnosis.
Safety and tolerability data were not reported. Key limitations include the single-center setting and the observational design, which only report associations, not causation. The practice relevance is that CDU with a cut-off of STV <43 cm/s may be a useful diagnostic tool for differentiating Graves' disease from silent thyroiditis, but generalizability may be limited.